infliximab
janssen
['ibd', 'infliximab', 'imab ']
adolescents and young adults with ibd can switch from the originator to a biosimilar of infliximab with no loss of response or increased side effects. #cccongress23 #ibd
No. 1–rated independent monthly newspaper providing news and information for 20,000+ gastroenterologists, colorectal surgeons, hepatologists, PAs and NPs.